Drug profile · INN
seladelpar lysine dihydrate
LYVDELZI (PREVIOUSLY SELADELPAR GILEAD)
seladelpar lysine dihydrate (LYVDELZI (PREVIOUSLY SELADELPAR GILEAD)) is a peroxisome proliferator-activated receptor delta agonist.
Drug details — seladelpar lysine dihydrate
- Class
- Alimentary tract and metabolism (A05)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
seladelpar lysine dihydrate (LYVDELZI (PREVIOUSLY SELADELPAR GILEAD)) is a peroxisome proliferator-activated receptor delta agonist.
Key facts
Mechanism of action
Peroxisome proliferator-activated receptor delta agonist
Primary target: Peroxisome proliferator-activated receptor delta
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is seladelpar lysine dihydrate?
seladelpar lysine dihydrate (LYVDELZI (PREVIOUSLY SELADELPAR GILEAD)) is a peroxisome proliferator-activated receptor delta agonist.
What is the brand name for seladelpar lysine dihydrate?
LYVDELZI (PREVIOUSLY SELADELPAR GILEAD) is a marketed brand name for seladelpar lysine dihydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.